PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
HIV Seropositivity D006679 15 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Chondrosarcoma D002813 9 associated lipids
Dirofilariasis D004184 3 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hypothermia D007035 19 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Parkinson Disease D010300 53 associated lipids
Down Syndrome D004314 18 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yamaguchi K and Hama H Separation of periventricular dopaminergic and alpha-adrenergic systems from the vasopressin-secreting mechanisms activated by prostaglandin D2. 1991 Brain Res. pmid:1665382
Giles H et al. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. 1991 Br. J. Pharmacol. pmid:1665742
Georgitis JW et al. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions. 1991 Int. Arch. Allergy Appl. Immunol. pmid:1666629
Takayanagi I et al. Effects of aging on alpha 2-adrenoceptor mechanisms in isolated guinea-pig tracheal preparations. 1991 Eur. J. Pharmacol. pmid:1674919
Goerg KJ et al. Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites. 1991 Am. J. Physiol. pmid:1676243
Fox CC et al. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. 1991 Dig. Dis. Sci. pmid:1703070
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Watanabe T et al. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. 1991 Blood pmid:1718495
Minc-Golomb D et al. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. 1991 EMBO J. pmid:1829676
Fukushima M [Prostaglandins and cell proliferation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024021
Morii H and Watanabe Y Solubilization of prostaglandin D2 binding protein from porcine temporal cortex. 1991 Biochem. Biophys. Res. Commun. pmid:1989614
Dore-Duffy P et al. Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. 1991 Neurology pmid:1992386
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Francis HP et al. BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. 1991 Br. J. Pharmacol. pmid:1797323
Jongejan R et al. Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. 1991 Eur. J. Pharmacol. pmid:1800116
Raphael GD et al. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. 1991 J. Allergy Clin. Immunol. pmid:1712803
Massey WA et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. 1991 J. Immunol. pmid:1715365
Butchers PR et al. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. 1991 Br. J. Pharmacol. pmid:1724629
Misawa M and Kanai Y Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. 1991 Arzneimittelforschung pmid:1725697
Abman SH and Accurso FJ Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. 1991 Am. J. Physiol. pmid:1847014
Sladek K et al. Formation of PGD2 after allergen inhalation in atopic asthmatics. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1847781
King LS et al. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. 1991 Circ. Res. pmid:1825033
Arzubiaga C et al. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. 1991 J. Allergy Clin. Immunol. pmid:1825102
Koshihara Y et al. Prostaglandin D2 stimulates calcification by human osteoblastic cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825424
Atsmon J et al. Modulation of the antiproliferative activity of 9-deoxy-delta 9,delta 12(E)-PGD2 by conjugation with intracellular glutathione. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825432
Koizumi K et al. Induction of 31,000 protein by PGD2-treated vascular endothelial cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825433
Morrow JD et al. A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825560
Howarth P et al. The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825579
Gundel RH et al. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primates. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825582
Watanabe K et al. The structure and function of prostaglandin F synthase. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825592
Gebicke-Haerter PJ et al. Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. 1991 J. Neurochem. pmid:1828830
Francis HP et al. The thromboxane receptor antagonist BAY u3405 reverses prostaglandin D2 (PGD2)-induced bronchoconstriction in the anaesthetised guinea pig. 1991 Ann. N. Y. Acad. Sci. pmid:1835329
Murakami M et al. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. 1991 FEBS Lett. pmid:1756867
McMahon TJ et al. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1991 J. Appl. Physiol. pmid:1837015
D'Onofrio C et al. The antiproliferative effect of prostaglandin A and J on HTLV-I transformed cells is associated with induction of a heat-shock protein. 1990 Sep-Oct Pharmacol. Res. pmid:2284244
Khan SH and Sorof S Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. 1990 Proc. Natl. Acad. Sci. U.S.A. pmid:2251282
Nishimura G [Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. 1990 Nihon Gan Chiryo Gakkai Shi pmid:2351856
Ford WD et al. Pulmonary hypertension in lambs with congenital diaphragmatic hernia: vasodilator prostaglandins, isoprenaline, and tolazoline. 1990 J. Pediatr. Surg. pmid:2352080
Okumura T and Saito K Effect of prostaglandins on glycogenesis and glycogenolysis in primary cultures of rat hepatocytes--a role of prostaglandin D2 in the liver. 1990 Prostaglandins pmid:2353117
Perreault T et al. Pulmonary vascular effects of prostaglandin D2 in newborn pig. 1990 Am. J. Physiol. pmid:2337164
Ingenito EP et al. Bronchoalveolar lavage cell and mediator responses to hyperpnea-induced bronchoconstriction in the guinea pig. 1990 Am. Rev. Respir. Dis. pmid:2339838
Vigano' T et al. Binding sites for histamine and sulfidopeptide leukotrienes in normal and hypersensitized human lung fragments. 1990 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2144691
Fukushima M Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved. 1990 Eicosanoids pmid:2073399
Inoue M et al. Interactions between the brain renin-angiotensin system and brain prostanoids in the control of vasopressin secretion. 1990 Exp Brain Res pmid:2073934
Bennegård B et al. Luteotropic effects of prostaglandins I2 and D2 on isolated human corpora luteum. 1990 Fertil. Steril. pmid:2168845
Bettazzoli L et al. Incorporation of arachidonic acid into glycerophospholipids of a murine bone marrow derived mast cell. 1990 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2169185
Brass EP and Garrity MJ Structural specificity for prostaglandin effects on hepatocyte glycogenolysis. 1990 Biochem. J. pmid:2158311
Virgolini I et al. Effects of bopindolol on platelet function in hypertension at rest and during exercise. 1990 Prostaglandins Leukot. Essent. Fatty Acids pmid:2143586
Nakahata N et al. PGJ2 and delta 12PGJ2 inhibit cell growth accompanied with inhibition of phosphoinositide turnover in human astrocytoma cells. 1990 Prostaglandins pmid:2177901
Massey WA and Lichtenstein LM The effects of antihistamines beyond H1 antagonism in allergic inflammation. 1990 J. Allergy Clin. Immunol. pmid:1979797